Professor MD, PhD, DMSc
Jens Kjølseth Møller
Department of Clinical Microbiology, Lillebaelt Hospital and Department of Regional Health Research, University of Southern Denmark, Denmark
Project management | ||
Project status | Open | |
Data collection dates | ||
Start | 01.01.2025 | |
End | 31.12.2026 | |
Urosepsis is defined as a blood stream infection caused by an infection in the urogenital tract. In a retrospective cohort study based on registry data from patients admitted to a single Danish hospital centre, the risk factors for and the mortality of urosepsis cases with E. coli are examined. The outcome of urosepsis is furthermore assessed in relation to the antibiotic treatment of the patient and the antibiotic resistance of the infection-causing bacteria.
Urosepsis is a life-threatening infection with high morbidity and mortality, where the triggering infection in the urogenital tract is not always detected. Effective antibiotic treatment of urosepsis also require treatment of the underlying focal infection. What is the validity of diagnosis codes in LPR for patients suspected of urosepsis. What is the trend in mortality rates in a Danish cohort of urosepsis patients with documented blood stream infection during the study period? Which risk factors are associated with mortality? Do patients with urosepsis receive appropriate empirical antimicrobial therapy? Do clinicians tailor their final antibiotic therapy to the resistance patterns of the pathogens reported to the clinical department in charge of the patients?
Adults admitted to a Danish hospital with urinary tract infection and bacteraemia between 2007 and 2023.
Data from the electronic laboratory system in clinical microbiology (MADS) and clinical biochemistry (LABKA and BCC), the medication module of the hospital electronic patient records, the National Patient Registry (LPR_ADM), Cause of Death Registry (DAR), The Danish National Prescription Registry (LMDB), and the socioeconomic registries UDDF, IND, and FAIK.